Skip to main content
OpenTrials

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

270 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Completed

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

NCT03665285

Conditions
Adenocarcinoma, Advanced or Metastatic Solid Tumors, Breast Cancer, +45 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Laura and Isaac Perlmutter Cancer Center New York, United States
View Trial Details
Completed

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

NCT03219268

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +48 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 40 locations
View Trial Details
Completed

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

NCT03833661

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +19 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • UCSF Mount Zion Medical Ctr San Francisco, California, United States
  • Mayo Clinic in Florida - Department of Neurology Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute, Inc Tampa, Florida, United States
View all 33 locations
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions